✦ LIBER ✦

Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk

✍ Scribed by E. Mannucci; C.M. Rotella

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucagon-Like Peptide-1 and its Cardiova

✍ Kyung-Sun Heo, Keigi Fujiwara, Jun-ichi Abe 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 270 KB

Glucagon-like peptide-1, glucose homeost

✍ Jens J. Holst; Carolyn F. Deacon; Tina Vilsbøll; Thure Krarup; Sten Madsbad 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 674 KB

On the Treatment of Diabetes Mellitus wi

✍ JENS JUUL HOLST; CAROLYN DEACON; MAJ-BRIT TOFT-NIELSEN; LOTTE BJERRE-KNUDSEN 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Beneficial effects of once-daily liraglu

✍ J.-P. Courrèges; T. Vilsbøll; M. Zdravkovic; T. Le-Thi; T. Krarup; O. Schmitz; R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

Glucagon-like peptide 1 and its derivati

✍ Michael A. Nauck; Juris J. Meier 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 913 KB

Glucagon-like peptide-1 (GLP-1) receptor

✍ D. J. Drucker; C. F. Rosen 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 130 KB